Complement-Mediated Microglial Phagocytosis and Pathological Changes in the Development and Degeneration of the Visual System
- PMID: 33072106
 - PMCID: PMC7541817
 - DOI: 10.3389/fimmu.2020.566892
 
Complement-Mediated Microglial Phagocytosis and Pathological Changes in the Development and Degeneration of the Visual System
Abstract
The focus of this review is the role of complement-mediated phagocytosis in retinal and neurological diseases affecting the visual system. Complement activation products opsonize synaptic material on neurons for phagocytic removal, which is a normal physiological process during development, but a pathological process in several neurodegenerative diseases and conditions. We discuss the role of complement in the refinement and elimination of synapses in the retina and lateral geniculate nucleus, both during development and in disease states. How complement and aberrant phagocytosis promotes injury to the visual system is discussed primarily in the context of multiple sclerosis, where it has been extensively studied, although the role of complement in visual dysfunction in other diseases such as stroke and traumatic brain injury is also highlighted. Retinal diseases are also covered, with a focus on glaucoma and age-related macular degeneration. Finally, we discuss the potential of complement inhibitory strategies to treat diseases affecting the visual system.
Keywords: age-related macular degeneration; complement; glaucoma; lateral geniculate nucleus; multiple sclerosis; phagocytosis; retina; synapse.
Copyright © 2020 Borucki, Toutonji, Couch, Mallah, Rohrer and Tomlinson.
Figures
              
              
              
              
                
                
                
              
              
              
              
                
                
                References
Publication types
MeSH terms
Substances
Grants and funding
- I01 BX004256/BX/BLRD VA/United States
 - I21 RX002363/RX/RRD VA/United States
 - I01 RX001141/RX/RRD VA/United States
 - TL1 TR001451/TR/NCATS NIH HHS/United States
 - IK6 BX005235/BX/BLRD VA/United States
 
- T32 GM008716/GM/NIGMS NIH HHS/United States
 - T32 AI132164/AI/NIAID NIH HHS/United States
 - UL1 TR001450/TR/NCATS NIH HHS/United States
 - IK6 BX004858/BX/BLRD VA/United States
 - P30 DK123704/DK/NIDDK NIH HHS/United States
 - I01 BX003050/BX/BLRD VA/United States
 - R01 EY024581/EY/NEI NIH HHS/United States
 - I01 RX000444/RX/RRD VA/United States
 
LinkOut - more resources
Full Text Sources
Medical
